Anheuser-Busch Inbev Sa (BUD) 129.58 $BUD Anheuser-Busch

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Anheuser-Busch Inbev Sa (BUD) 129.58 $BUD

Anheuser-Busch InBev Set to Possibly Rebound After Yesterday's Selloff of 5.08%
Comtex SmarTrend(R) - Fri Jun 24, 3:27PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $122.49 to a high of $125.82. Yesterday, the shares fell 5.1%, which took the trading range below the 3-day low of $127.98 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BUD: 129.58 (+1.13)

After Yesterday's Rally of 2.37% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 20, 2:08PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $127.12 to a high of $128.83. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $125.66 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BUD: 129.58 (+1.13)

After Yesterday's Decline of 2.95%, Anheuser-Busch InBev Offers Investors Better Value
Comtex SmarTrend(R) - Fri Jun 10, 1:10PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $126.03 to a high of $127.01. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $129.32 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BUD: 129.58 (+1.13)

5 European Stocks to Buy as ECB Unleashes More Stimulus
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 9:56AM CDT
ECB launched corporate bond purchases for the first time ever on June 8, adding investment grade credit to its asset purchases.
BUD: 129.58 (+1.13), GS: 152.66 (+4.52), TEF: 10.50 (+0.42), FCAU: 7.19 (+0.27), BAC: 14.04 (+0.43)

Are Consumer Staples Stocks Poised for Strong Growth?
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 3:56PM CDT
Are Consumer Staples Stocks Poised for Strong Growth?
MDLZ: 44.85 (+0.67), MKC: 102.40 (+2.23), CAG: 47.91 (+0.51), THS: 98.66 (+1.86), KMB: 133.96 (+0.80), SYY: 50.29 (+0.32), WMT: 72.10 (+0.35), PEP: 104.44 (+0.70), K: 77.83 (+0.48), DPS: 92.57 (+0.46), TGT: 69.78 (+0.92), DF: 17.58 (+0.11), RAI: 50.84 (-0.13), KO: 45.08 (+0.22), HYH: 33.49 (+0.72), BUD: 129.58 (+1.13), JJSF: 113.53 (+2.25), TAP: 101.95 (+0.44), MO: 66.31 (+0.16), WWAV: 46.69 (+0.74), PM: 101.90 (+0.87), UNFI: 45.74 (+0.75), BGS: 46.65 (+0.88), TJX: 76.88 (-0.15), KHC: 86.37 (+1.16), MCD: 121.21 (+0.59), PF: 44.16 (+0.13), PG: 84.21 (+0.64), GIS: 66.77 (+0.37)

Anheuser-Busch InBev Rises 1.22% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jun 06, 2:03PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $129.51 to a high of $130.80. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $129.12 on volume of 718,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BUD: 129.58 (+1.13)

Starbucks/Anheuser-Busch to Bring Ready-to-Drink Tea in U.S.
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 9:52AM CDT
Starbucks announced plans to bring Teavana ready-to-drink (RTD) tea in the U.S. in partnership with Anheuser-Busch InBev SA/NV (BUD) in the first half of 2017.
SBUX: 56.13 (+0.52), QSR: 43.21 (+0.86), BUD: 129.58 (+1.13), PEP: 104.44 (+0.70)

Anheuser-Busch InBev Set to Possibly Pullback After Yesterday's Rally of 1.17%
Comtex SmarTrend(R) - Wed Jun 01, 12:26PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $126.13 to a high of $128.38. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $127.44 on volume of 946,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BUD: 129.58 (+1.13)

Molson Coors Hits 52-Week High on EU Nod to Beer Deal
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:56AM CDT
Shares of Molson Coors Brewing Company (TAP) hit a 52-week high of $100.62 on May 27, after regulators with the European Commission approved the potential merger of beer giants Anheuser-Busch InBev (BUD) and its rival SABMiller plc (SBMRY).
BUD: 129.58 (+1.13), TAP: 101.95 (+0.44), MO: 66.31 (+0.16)

Teamsters Protest Molson Coors Shareholders' Meeting In Denver
PR Newswire - Wed May 25, 2:03PM CDT
Today, Teamsters protested outside the Molson Coors (NYSE:TAP) annual meeting of shareholders in Denver and raised concerns inside the meeting about the planned closure of the award-winning MillerCoors brewery in Eden, N.C.
BUD: 129.58 (+1.13), TAP: 101.95 (+0.44)

After Yesterday's Rally of 1.12% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed May 25, 1:36PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $126.18 to a high of $127.44. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $125.37 on volume of 854,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BUD: 129.58 (+1.13)

EU gives go-ahead for huge beer merger
AP - Tue May 24, 11:02AM CDT
LONDON (AP) — The European Union's regulator has given the go-ahead to the proposed merger of Anheuser-Busch InBev and SABMiller, clearing another hurdle for the combination of the world's two biggest beer makers.
BUD: 129.58 (+1.13)

2015 was a corporate buyout bonanza; here comes the sequel
By The Associated Press - AP - Mon May 23, 3:41PM CDT
After 2015's blistering global buyout pace, this year is shaping up to be quite the sequel with Bayer's $62 billion attempt to buy Monsanto and create a global seed giant.
BUD: 129.58 (+1.13), MON: 109.15 (+1.99)

SmarTrend Watching for Potential Rebound in Shares of Anheuser-Busch InBev After 1.03% Loss
Comtex SmarTrend(R) - Tue May 17, 2:37PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $123.94 to a high of $124.69. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $124.71 on volume of 561,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BUD: 129.58 (+1.13)

New Strong Sell Stocks for May 17th
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:18AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
BUD: 129.58 (+1.13), ACAT: 16.88 (+0.30), MTGE: 15.79 (+0.04), AU: 15.78 (-0.08), ABBV: 61.31 (+0.92)

Molson Coors Brewing, AB InBev and Walt Disney highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Wed May 11, 8:30AM CDT
Molson Coors Brewing, AB InBev and Walt Disney highlighted as Zacks Bull and Bear of the Day
BUD: 129.58 (+1.13), DIS: 99.02 (+0.23), TAP: 101.95 (+0.44)

SmarTrend Watching for Potential Pullback in Shares of Anheuser-Busch InBev After 1.24% Gain
Comtex SmarTrend(R) - Mon May 09, 1:52PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $125.64 to a high of $127.10. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $125.60 on volume of 776,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BUD: 129.58 (+1.13)

Company News for May 05, 2016
Zacks Equity Research - Zacks Investment Research - Thu May 05, 9:10AM CDT
Companies in the News are: CAR,BUD,MTCH,Z
BUD: 129.58 (+1.13), MTCH: 15.60 (+0.29), CAR: 34.81 (+1.34), Z: 35.38 (+0.79)

Anheuser-Busch InBev Falls 2.30% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed May 04, 12:09PM CDT
Anheuser-Busch InBev (NYSE:BUD) traded in a range yesterday that spanned from a low of $121.68 to a high of $123.43. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $123.72 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BUD: 129.58 (+1.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
JOIA Rose Hall Revives Jamaican Luxury Experience

Updated Category News Views 78

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Continue Reading
Florida's Natural, Johnsonville Settle Bet Over Juice

Updated Category News Views 63

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Guidewire Celebrates P&C Insurance Innovators

Updated Category News Views 50

P&C Insurance Takes Center Stage If there's one thing that gets the blood pumping at a conference, it's innovation. This year, Guidewire pulled out all the stops at their Connections Conference in Las Vegas, spotlighting customer and partner triumphs in the P&C insurance sector. From Guidewire Innovation Awards to Partner Excellence Awards, the event was an ode to...

Continue Reading
Veralto Sees Strong Q3 2026 Growth, Eyes 2027 Gains

Updated Category News Views 22

Veralto's Stellar Third Quarter Performance Jumping right into the thick of it, Veralto's third quarter 2026 numbers aren't just a flash in the pan. We're talking a solid sales boost of 7.5%, reaching the magic number of $1,509 million. If you're holding NYSE:VLTO, these figures are a good look. It's not every day you see an operating profit margin hovered at an...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 48

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 57

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Domestic Violence Laws: A Broken Shield Revealed

Updated Category News Views 24

A Look at Where Policies Stumble Life's got no script for chaos, and you'd think the laws meant to protect folks from domestic violence would at least have a solid plan. Turns out, that's not always the case. Bloomberg Law just pulled back the curtain in a stinging investigation that exposes the gaping holes in these well-meaning policies. Why spill my morning coffee over...

Continue Reading
Quaker Houghton Propels Forward with Q3 2026 Gains

Updated Category News Views 28

Quaker Houghton's Strategy Yields Positive Q3 2026 Results Imagine getting through another quarter against global economic headwinds and coming out profitable. That’s exactly what Quaker Houghton (NYSE:KWR) pulled off in Q3 2026. Their net sales jumped to a solid $544.5 million, marking a 10% increase from the same quarter last year. Not bad for a company that had its...

Continue Reading

Top 5 Most Recently Viewed Articles

Medtronic's Sphere-360™ Catheter Receives CE Mark and US IDE Milestones

Updated Category News Views 160

Medtronic Achieves Major Milestones with Sphere-360™ Catheter In a significant development for the treatment of atrial fibrillation, Medtronic plc (NYSE: MDT) announced the receipt of the CE Mark for its Sphere-360™ single-shot pulsed field ablation (PFA) catheter. This innovative device is specifically designed to treat paroxysmal atrial fibrillation (AFib)...

Continue Reading
Oculis Holding AG Announces Participation in Investor Events

Updated Category News Views 178

Oculis Holding AG Engaging with Investors at Conferences Based in Switzerland, Oculis Holding AG (Nasdaq: OCS; Iceland: OCS) is a trailblazer in the biopharmaceutical industry, dedicated to pioneering treatments for ophthalmic and neuro-ophthalmic conditions. Today, Oculis is eager to convey its latest advancements at several prestigious upcoming investor conferences,...

Continue Reading
Freshpet CEO Implements Strategic Trading Plan for Shares

Updated Category News Views 159

Freshpet's Leadership Takes Initiative with Trading Plans Freshpet, Inc. (NASDAQ: FRPT), a leading name in fresh pet food, is making headlines as its Chief Executive Officer, Billy Cyr, shares his plans to adopt a Rule 10b5-1 trading strategy. This proactive approach is designed for the exercise of stock options that were granted back in 2016, with a looming expiration on...

Continue Reading
NOMAD Power Steps Into AI Energy Arena with Ticker NMAD

Updated Category News Views 14

From Reagents to Railways: The NOMAD Transformation Jumping straight from the lab to the electric grid, former biotech player LIXTE Biotechnology Holdings, Inc. has completed a dramatic pivot, emerging as NOMAD Power Solutions, Inc. (NASDAQ: NMAD). This isn't your everyday ticker change—it's a full-fledged identity overhaul that repositions them smack in the midst of AI...

Continue Reading
Novaturas Reports 2024 Half-Year Financial Performance

Updated Category News Views 93

Novaturas Reveals Half-Year Financial Results for 2024 On August 23, Kristijonas Kaikaris, the CEO of AB “Novaturas,” along with Interim CFO Auks? Kriau?i?nait?, presented the company's consolidated financial results for the first half of 2024 to investors. This report highlights the key financial indicators for Novaturas Group and its operations during this time...

Continue Reading